Search

Sara Elizabeth Townsley

Examiner (ID: 5080, Phone: (571)270-7672 , Office: P/1629 )

Most Active Art Unit
1629
Art Unit(s)
1629, 1612, 1613
Total Applications
512
Issued Applications
97
Pending Applications
84
Abandoned Applications
350

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5429157 [patent_doc_number] => 20090088467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-02 [patent_title] => 'VITAMIN E SUPPLEMENTATION TO TETANUS TOXOID' [patent_app_type] => utility [patent_app_number] => 12/243839 [patent_app_country] => US [patent_app_date] => 2008-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 12446 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20090088467.pdf [firstpage_image] =>[orig_patent_app_number] => 12243839 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/243839
Vitamin E supplementation to tetanus toxoid Sep 30, 2008 Issued
Array ( [id] => 6403072 [patent_doc_number] => 20100305214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'Use of a Monoterpene to Increase Tissue Repair' [patent_app_type] => utility [patent_app_number] => 12/679995 [patent_app_country] => US [patent_app_date] => 2008-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7040 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20100305214.pdf [firstpage_image] =>[orig_patent_app_number] => 12679995 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/679995
Use of a Monoterpene to Increase Tissue Repair Sep 26, 2008 Abandoned
Array ( [id] => 6453751 [patent_doc_number] => 20100189672 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'DECALINE DERIVATIVES AS PERFUMING INGREDIENTS' [patent_app_type] => utility [patent_app_number] => 12/677723 [patent_app_country] => US [patent_app_date] => 2008-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4456 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20100189672.pdf [firstpage_image] =>[orig_patent_app_number] => 12677723 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/677723
DECALINE DERIVATIVES AS PERFUMING INGREDIENTS Sep 22, 2008 Abandoned
Array ( [id] => 6388603 [patent_doc_number] => 20100317679 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'SUBSTITUTED ARYL-FUSED SPIROCYCLIC AMINES' [patent_app_type] => utility [patent_app_number] => 12/678782 [patent_app_country] => US [patent_app_date] => 2008-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18870 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20100317679.pdf [firstpage_image] =>[orig_patent_app_number] => 12678782 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/678782
SUBSTITUTED ARYL-FUSED SPIROCYCLIC AMINES Sep 18, 2008 Abandoned
Array ( [id] => 5272187 [patent_doc_number] => 20090075963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'TRANSDERMAL HORMONE SPRAY' [patent_app_type] => utility [patent_app_number] => 12/209961 [patent_app_country] => US [patent_app_date] => 2008-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9241 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20090075963.pdf [firstpage_image] =>[orig_patent_app_number] => 12209961 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/209961
TRANSDERMAL HORMONE SPRAY Sep 11, 2008 Abandoned
Array ( [id] => 5350081 [patent_doc_number] => 20090005442 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING NEURODEGENERATIVE DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/207816 [patent_app_country] => US [patent_app_date] => 2008-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6048 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20090005442.pdf [firstpage_image] =>[orig_patent_app_number] => 12207816 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/207816
CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING NEURODEGENERATIVE DISORDERS Sep 9, 2008 Abandoned
Array ( [id] => 5324416 [patent_doc_number] => 20090062406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'Aqueous concentrates of isethionate, taurate and betaine' [patent_app_type] => utility [patent_app_number] => 12/231209 [patent_app_country] => US [patent_app_date] => 2008-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4782 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20090062406.pdf [firstpage_image] =>[orig_patent_app_number] => 12231209 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/231209
Aqueous concentrates of isethionate, taurate and betaine Aug 28, 2008 Abandoned
Array ( [id] => 5958434 [patent_doc_number] => 20110182821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'CLUSTERED MAGNETIC PARTICLES AS TRACERS FOR MAGNETIC PARTICLE IMAGING' [patent_app_type] => utility [patent_app_number] => 12/674444 [patent_app_country] => US [patent_app_date] => 2008-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2737 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20110182821.pdf [firstpage_image] =>[orig_patent_app_number] => 12674444 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/674444
CLUSTERED MAGNETIC PARTICLES AS TRACERS FOR MAGNETIC PARTICLE IMAGING Aug 27, 2008 Abandoned
Array ( [id] => 5336712 [patent_doc_number] => 20090053176 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'New Combination 937' [patent_app_type] => utility [patent_app_number] => 12/195505 [patent_app_country] => US [patent_app_date] => 2008-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10121 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20090053176.pdf [firstpage_image] =>[orig_patent_app_number] => 12195505 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/195505
New Combination 937 Aug 20, 2008 Abandoned
Array ( [id] => 5984819 [patent_doc_number] => 20110097410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'FORMULATIONS OF PX COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/674743 [patent_app_country] => US [patent_app_date] => 2008-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7023 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20110097410.pdf [firstpage_image] =>[orig_patent_app_number] => 12674743 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/674743
FORMULATIONS OF PX COMPOUNDS Aug 20, 2008 Abandoned
Array ( [id] => 8577815 [patent_doc_number] => 08344025 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-01 [patent_title] => 'Oxalic acid derivatives and use thereof as physiological cooling active ingredients' [patent_app_type] => utility [patent_app_number] => 12/193375 [patent_app_country] => US [patent_app_date] => 2008-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18085 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12193375 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/193375
Oxalic acid derivatives and use thereof as physiological cooling active ingredients Aug 17, 2008 Issued
Array ( [id] => 5447007 [patent_doc_number] => 20090048233 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'Enhancing the Tolerability of a Seratonin Antagonist and a NSRI, a SNRI or a RIMA by Using Them in Combination' [patent_app_type] => utility [patent_app_number] => 12/192591 [patent_app_country] => US [patent_app_date] => 2008-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28965 [patent_no_of_claims] => 143 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20090048233.pdf [firstpage_image] =>[orig_patent_app_number] => 12192591 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/192591
Enhancing the Tolerability of a Seratonin Antagonist and a NSRI, a SNRI or a RIMA by Using Them in Combination Aug 14, 2008 Abandoned
Array ( [id] => 7731725 [patent_doc_number] => 20120015032 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'COMBINATION PREPARATION COMPRISING INHIBITOR OF HMG-COA REDUCTASE AND ASPIRIN AND METHOD FOR MANUFACTURING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/672630 [patent_app_country] => US [patent_app_date] => 2008-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17542 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20120015032.pdf [firstpage_image] =>[orig_patent_app_number] => 12672630 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/672630
COMBINATION PREPARATION COMPRISING INHIBITOR OF HMG-COA REDUCTASE AND ASPIRIN AND METHOD FOR MANUFACTURING THE SAME Aug 7, 2008 Abandoned
Array ( [id] => 5297248 [patent_doc_number] => 20090012174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'Compositions Having a High Antiviral and Antibacterial Efficacy' [patent_app_type] => utility [patent_app_number] => 12/188714 [patent_app_country] => US [patent_app_date] => 2008-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15872 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20090012174.pdf [firstpage_image] =>[orig_patent_app_number] => 12188714 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/188714
Compositions Having a High Antiviral and Antibacterial Efficacy Aug 7, 2008 Abandoned
Array ( [id] => 7817501 [patent_doc_number] => 20120064121 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'PYRIDINE COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES' [patent_app_type] => utility [patent_app_number] => 12/452983 [patent_app_country] => US [patent_app_date] => 2008-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18333 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20120064121.pdf [firstpage_image] =>[orig_patent_app_number] => 12452983 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/452983
PYRIDINE COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES Jul 30, 2008 Abandoned
Array ( [id] => 5361664 [patent_doc_number] => 20090036458 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-05 [patent_title] => 'ENDOPARASITICIDAL TOPICAL COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 12/182253 [patent_app_country] => US [patent_app_date] => 2008-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2497 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20090036458.pdf [firstpage_image] =>[orig_patent_app_number] => 12182253 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/182253
ENDOPARASITICIDAL TOPICAL COMPOSITIONS Jul 29, 2008 Abandoned
Array ( [id] => 5447114 [patent_doc_number] => 20090048340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'GROWTH HORMONE SECRETION REGULATOR' [patent_app_type] => utility [patent_app_number] => 12/182544 [patent_app_country] => US [patent_app_date] => 2008-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6029 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20090048340.pdf [firstpage_image] =>[orig_patent_app_number] => 12182544 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/182544
GROWTH HORMONE SECRETION REGULATOR Jul 29, 2008 Abandoned
Array ( [id] => 5338012 [patent_doc_number] => 20090054476 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'A3 Adenosine receptor allosteric modulators' [patent_app_type] => utility [patent_app_number] => 12/219772 [patent_app_country] => US [patent_app_date] => 2008-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16166 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20090054476.pdf [firstpage_image] =>[orig_patent_app_number] => 12219772 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/219772
A3 adenosine receptor allosteric modulators Jul 27, 2008 Issued
Array ( [id] => 5453230 [patent_doc_number] => 20090069267 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'CENTRAL ADMINISTRATION OF STABLE FORMULATIONS OF THERAPEUTIC AGENTS FOR CNS CONDITIONS' [patent_app_type] => utility [patent_app_number] => 12/180373 [patent_app_country] => US [patent_app_date] => 2008-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 22104 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20090069267.pdf [firstpage_image] =>[orig_patent_app_number] => 12180373 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/180373
CENTRAL ADMINISTRATION OF STABLE FORMULATIONS OF THERAPEUTIC AGENTS FOR CNS CONDITIONS Jul 24, 2008 Abandoned
Array ( [id] => 6455367 [patent_doc_number] => 20100189783 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'RELATING TO ANTI-HIV TABLET FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 12/670030 [patent_app_country] => US [patent_app_date] => 2008-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3470 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20100189783.pdf [firstpage_image] =>[orig_patent_app_number] => 12670030 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/670030
RELATING TO ANTI-HIV TABLET FORMULATIONS Jul 24, 2008 Abandoned
Menu